Contaminated blood thinner heparin called a worldwide problem
Los Angeles Times, April 22, 2008
A contaminated blood thinner from China has become a worldwide public health problem, with 10 other countries detecting the often-toxic ingredient, according to federal investigators. The compound, which mimics the real blood thinner heparin but which costs less to make, may have been added deliberately somewhere along a production chain that began on farms in China. Food and Drug Administration officials issued a warning letter that banned future U.S. shipments from the plant in China that supplied the widely used blood thinner until the safety issues are resolved.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Carondelet to Pay $35M to Settle Fraud Allegations
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- 3 Traits Personality Assessments Can't Reveal
- CA Powers Up $80M HIE to 'Create Value in the Data'